- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03991247
Evaluation of Spa Treatment on Insomnia (SOMNOTHERM)
Evaluation of Psychosomatic Spa Treatment With Crenotherapy to Potentiate the Implementation of Behavioral Measures for Insomnia Disorder Management
Persistant insomnia is a common sleep disorder that affects approximately 20% of the French population. The standard treatment for chronic insomnia is Cognitive-Behavioral Therapy (CBT).
Behavioral measures can be difficult to implement for the patient alone at home.
Spa therapy with psychosomatic orientation allows to implement hygiene rules and structure rhythms of life. In addition, recent studies have shown that spa treatment, including crenotherapy, is effective in somatic complaints related to anxiety and benzodiazepine withdrawal.
The spa treatment could therefore provide ideal conditions for the implementation of behavioral measures for insomnia management.
The objective of SOMNOTHERM study is to measure efficiency on insomnia complaints at 8 weeks of a the implementation of a Behavioral therapy program for insomnia delivered by an internet software combined to a spa treatment compared to implementation of the same program at home (standard care).
Study Overview
Status
Conditions
Detailed Description
Persistant insomnia is a common sleep disorder that affects approximately 20% of the French population.
The standard treatment for chronic insomnia is Cognitive-Behavioral Therapy (CBT). This therapy is based on 4 components: sleep restriction, stimulus control, cognitive therapy and sleep hygiene education. Unfortunately, there are an insufficient number of trained CBT experts especially in France.
Online programs based on CBT principles (e-CBT) have been proved to be effective in improving the sleep and daytime functioning in this population. Thus e-CBT can be an effective alternative to conventional CBT.
Behavioral measures, however, remains difficult for patients to implement alone at home.
Spa therapy with psychosomatic orientation allows to implement hygiene rules and structure rhythms of life. In addition, recent studies have shown that spa treatment, including crenotherapy, is effective in somatic complaints related to anxiety and benzodiazepine withdrawal.
In this context, spa treatment with psychosomatic orientation appears conducive to implement hygiene rules and structure rhythms of life. The spa treatment could therefore provide ideal conditions for the implementation of behavioral measures of insomnia management (sleep hygiene, stimulus control and time in bed restriction) and could have a very beneficial effect on persistent insomnia disorder.
This non-pharmacological therapy could also reduce hypnotics consumption (especially benzodiazepine).
The main hypothesis of the study is that behavioral measures of insomnia management delivered by an internet software program combined to a spa treatment will be more effective on insomnia complaints (evaluated at 8 weeks) than the same program implemented at home.
Patients will be followed during 6 months after the beginning of the program. Subjects' recruitment will be carried out from the list of patients registered for a spa treatment in one of the five spa centers participating in the study (Les Thermes de Saujon, Les Grands Thermes de Bagnères de Bigorre, Les Thermes de Divonne-les-Bains, Les thermes de Néris-les-Bains, Les Thermes d'Ussat-les-Bains).
Study visits will be conducted by the coordinating center (CHU Bordeaux) by telephone interviews or video calls with participants.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jean-Arthur MICOULAUD-FRANCHI, MDPhD
- Phone Number: +33 557820173
- Email: jean-arthur.micoulaud-franchi@chu-bordeaux.fr
Study Contact Backup
- Name: Cécile KLOCHENDLER
- Phone Number: +33 557821159
- Email: cecile.klochendler@chu-bordeaux.fr
Study Locations
-
-
-
Bordeaux, France, 33000
- Recruiting
- University Hospital, Bordeaux
-
Contact:
- Jean-Arthur MICOULAUD-FRANCHI, MDPhD
- Phone Number: +33 557820173
- Email: jean-arthur.micoulaud-franchi@chu-bordeaux.fr
-
Contact:
- Cécile KLOCHENDLER
- Phone Number: +33 557821159
- Email: cecile.klochendler@chu-bordeaux.fr
-
Principal Investigator:
- Jean-Arthur MICOULAUD-FRANCHI, MDPhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female aged between 18 and 80 years old
- Registered at one of the participating spas, for a psychosomatic spa treatment scheduled for the next 12 months, but within a period of more than 16 weeks.
- ISI score ≥ 8 on the pre-selection questionnaire
- Person with a persistent insomnia disorder, with or without comorbidities, according to DSM 5
- Owning or having access to a computer / tablet or smartphone and to an internet connection
- Affiliated to a national health service
- Having given written informed consent to participate in the trial.
Exclusion Criteria:
- Strong suspicion of obstructive sleep apnea (OSA) syndrome on the STOP-BANG questionnaire and restless legs syndrome on the RLS screening questionnaire
- Having started antidepressant treatment in the last 2 months or whose treatment dose has been increased in the last 2 months
- Having started treatment with anxiolytic, hypnotic or neuroleptic in the last month or whose dosage of treatment has been increased in the last month
- Having carried out a spa treatment in the last 6 months, whatever the specialty.
- Registered to follow a complementary program for insomnia disorders during the planned spa treatment
- Pregnant or lactating women
- Major under guardianship or curatorship
- Night and shift-workers
- Having undertaken trans-meridian travel (± 3H) in the previous 1 month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Internet Behavioral therapy program + spa therapy
Patient following a program of computerized behavioral therapy for insomnia management during a 3 weeks spa treatment.
|
The online program consists in restriction of time in bed and stimulus control instructions. First, patient will complete an on-line sleep diary during 2 weeks. The personalized program is then activated by a practitioner (phone interview) who both assesses restriction of time in bed and delivers instructions of stimulus control. Then, restriction of time in bed is administered by the internet-delivered self-help program. The participant still completes his on-line sleep diary every day. Every 7 days, according mean sleep efficiency, a new sleep schedule recommendation is given to the participant. In addition, the program delivers everyday a set of instructions (stimulus control) designed to re-associate the bed/bedroom with sleep and to re-establish a consistent sleep wake schedule. The duration of restriction of time in bed program is 3 weeks (during spa treatment or at home depending on the allocated arm). Spa treatment is harmonized in the different stations. It consists in:
|
ACTIVE_COMPARATOR: Internet Behavioral therapy program at home
Patient following a program of computerized behavioral therapy for insomnia management during 3 weeks at home.
|
The online program consists in restriction of time in bed and stimulus control instructions. First, patient will complete an on-line sleep diary during 2 weeks. The personalized program is then activated by a practitioner (phone interview) who both assesses restriction of time in bed and delivers instructions of stimulus control. Then, restriction of time in bed is administered by the internet-delivered self-help program. The participant still completes his on-line sleep diary every day. Every 7 days, according mean sleep efficiency, a new sleep schedule recommendation is given to the participant. In addition, the program delivers everyday a set of instructions (stimulus control) designed to re-associate the bed/bedroom with sleep and to re-establish a consistent sleep wake schedule. The duration of restriction of time in bed program is 3 weeks (during spa treatment or at home depending on the allocated arm). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insomnia Severity Scale (ISI) score
Time Frame: Week 10 = 8 weeks after beginning of computerized behavioral therapy (starting of time in bed restriction)
|
7-item questionnaire assessing insomnia nature, severity and impact.
The global score ranges from 0 to 28.
|
Week 10 = 8 weeks after beginning of computerized behavioral therapy (starting of time in bed restriction)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total sleep time (TST) obtained by sleep diary
Time Frame: Every night between starting of sleep diary completion (Day 0) and Month 6 (study termination)
|
Total sleep time = total sleep episode minus awake time.
Subject records in his online sleep diary bedtime, wake-up time, time asleep, intra-night awakenings.
|
Every night between starting of sleep diary completion (Day 0) and Month 6 (study termination)
|
Sleep efficiency (SE) obtained by sleep diary
Time Frame: Every night between starting of sleep diary completion (Day 0) and Month 6 (study termination)
|
Ratio of total sleep time (TST) to time in bed (TIB) (multiplied by 100 to yield a percentage). Subject records in his online sleep diary bedtime, wake-up time, time asleep, intra-night awakenings. |
Every night between starting of sleep diary completion (Day 0) and Month 6 (study termination)
|
Sleep latency obtained by sleep diary
Time Frame: Every night between starting of sleep diary completion (Day 0) and Month 6 (study termination)
|
Length of time to accomplish the transition from full wakefulness to sleep.
Subject records in his online sleep diary bedtime, wake-up time, time asleep, intra-night awakenings.
|
Every night between starting of sleep diary completion (Day 0) and Month 6 (study termination)
|
Insomnia Severity Scale (ISI) score
Time Frame: On Day 0, Week 5, Week 7, Month 4, Month 6
|
7-item questionnaire that assesses insomnia nature, severity and impact.
|
On Day 0, Week 5, Week 7, Month 4, Month 6
|
EQ-5-D
Time Frame: On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
Standardized instrument for measuring generic health status.
|
On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
The Presleep State Arousal Scale (PSAS)
Time Frame: On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
16-item questionnaire assessing whether the respondent experienced somatic (8 items, eg heart rate) or cognitive hyperarousal (eg racing thoughts) at bedtime
|
On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
Hospital Anxiety and Depression Scale (HAD)
Time Frame: On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
14-item scale that generates ordinal data.
Seven of the items relate to anxiety and seven relate to depression.
|
On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
Short Version of the Functional Outcomes of Sleep Questionnaire (FOSQ)
Time Frame: On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
10 item questionnaire assessing the impact of excessive sleepiness on activities of daily living
|
On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
Rate of discontinuation and rate of reduction of anxiolytic hypnotic drugs and hypnotics
Time Frame: On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
Every day anxiolytic hypnotic drugs and hypnotics daily dose
|
On Day 0, Week 5, Week 7, Week 10, Month 4, Month 6
|
Acceptability E-scale (AES)
Time Frame: On week 10 (after computerized behavioral therapy program)
|
6-item self-reported questionnaire that evaluates the extent to which patients find E-health systems acceptable
|
On week 10 (after computerized behavioral therapy program)
|
Client Satisfaction Questionnaire (CSQ-8)
Time Frame: On week 10 (after computerized behavioral therapy program)
|
8-item questionnaire easily scored and administered measurement that is designed to measure client satisfaction with services.
|
On week 10 (after computerized behavioral therapy program)
|
Sleep Condition Indicator (SCI)
Time Frame: On Day 0
|
brief 8-item scale which measures sleep problems against the DSM-5 criteria for insomnia disorder
|
On Day 0
|
The Pittsburgh Sleep Quality Index (PSQI)
Time Frame: On Day 0
|
self-report questionnaire that assesses sleep quality over a 1-month time interval
|
On Day 0
|
Cognitive Scale of Attachment to Benzodiazepines ("Echelle cognitive d'attachement aux benzodiazépines" ECAB)
Time Frame: On Day 0
|
10-item scale assessing cognitive component of attachment to benzodiazepines
|
On Day 0
|
The Munich ChronoType Questionnaire (MCTQ)
Time Frame: On Day 0
|
Questionnaire to determine Chrono Type.
|
On Day 0
|
The Epworth Sleepiness Scale (ESS)
Time Frame: On Day 0
|
8-item questionnaire assessing daytime sleepiness
|
On Day 0
|
Freiburg Mindfulness Inventory - short version (FMI)
Time Frame: On Day 0
|
questionnaire for measuring mindfulness
|
On Day 0
|
Krueger's personality inventory for DSM-5 in its brief form (PID-5-BF)
Time Frame: On Day 0
|
25-item self-report questionnaire assessing the presence and severity of the five maladaptive personality traits outlined in DSM-5.
|
On Day 0
|
The Arousal Predisposition Scale (APS)
Time Frame: On Day 0
|
12-item questionnaire assessing whether the respondent considers her/himself a stressful and emotionally reactive person
|
On Day 0
|
The Ford Insomnia to Stress Scale (FIRST)
Time Frame: On Day 0
|
9-item questionnaire assessing whether past and future stressful events are likely to affect sleep quality
|
On Day 0
|
The "locus of control for technology"-questionnaire ("Kontrollüberzeugungen im Umgang mit Technik" - KUT)
Time Frame: On Day 0
|
8-item questionnaire assessing the specific interaction with technical environments of users
|
On Day 0
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C2018-01
- 2019-A00043-54 (OTHER: ANSM Number (ID-RCB))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Sunshine Lake Pharma Co., Ltd.Unknown
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
-
Butler HospitalSunovionCompleted
Clinical Trials on Computerized behavioral therapy program delivered by internet for insomnia management
-
Karolinska InstitutetRecruitingDepression | Anxiety Disorders | Insomnia | Psychiatric DisorderSweden
-
Megan PetrovTerminatedInsomnia Chronic | Subclinical Disease and/or SyndromeUnited States
-
Seattle Children's HospitalUniversity of VirginiaActive, not recruitingMigraine Disorders | Insomnia | Headache DisordersUnited States
-
I.M. Sechenov First Moscow State Medical UniversityUniversity of BernRecruitingChronic InsomniaRussian Federation
-
University of ReginaSaskatchewan Centre for Patient-Oriented ResearchCompletedDepression | Insomnia | AnxietyCanada
-
University of ArizonaRecruitingSleep Initiation and Maintenance DisordersUnited States
-
VA Eastern Colorado Health Care SystemUniversity of Colorado, Denver; Colorado Traumatic Brain Injury Trust FundRecruitingInsomnia | Traumatic Brain InjuryUnited States
-
VA Connecticut Healthcare SystemCompletedChronic InsomniaUnited States
-
University of PittsburghCompletedDepression | Anxiety | Sickle Cell DiseaseUnited States
-
Linkoeping UniversityOstergotland County Council, SwedenActive, not recruitingCardiac Anxiety | Non-cardiac Chest PainSweden